These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
656 related items for PubMed ID: 18193674
1. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit]. Wallén H, Agren A, Nekludov M. Lakartidningen; ; 104(48):3640-2. PubMed ID: 18193674 [No Abstract] [Full Text] [Related]
2. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Buresly K, Eisenberg MJ, Zhang X, Pilote L. Arch Intern Med; 2005 Apr 11; 165(7):784-9. PubMed ID: 15824298 [Abstract] [Full Text] [Related]
3. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Rubboli A, Halperin JL. Thromb Haemost; 2008 Nov 11; 100(5):752-3. PubMed ID: 18989515 [No Abstract] [Full Text] [Related]
4. [Acute coronary syndrome in patients using acetylsalicylic acid or warfarin]. Vik-Mo H, Hegbom K. Tidsskr Nor Laegeforen; 2004 Apr 22; 124(8):1105-6. PubMed ID: 15114389 [No Abstract] [Full Text] [Related]
6. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice. Prescrire Int; 2009 Dec 22; 18(104):272-3. PubMed ID: 20027714 [No Abstract] [Full Text] [Related]
12. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy. Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O. Aliment Pharmacol Ther; 2006 Feb 15; 23(4):489-95. PubMed ID: 16441469 [Abstract] [Full Text] [Related]
13. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel. Prescrire Int; 2009 Oct 15; 18(103):193-5. PubMed ID: 19877380 [Abstract] [Full Text] [Related]
14. Antiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: balancing safety and efficacy. Valgimigli M, Minarelli M. Am Heart J; 2010 Dec 15; 160(6 Suppl):S36-41. PubMed ID: 21147290 [Abstract] [Full Text] [Related]
15. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention. Porter A, Konstantino Y, Iakobishvili Z, Shachar L, Battler A, Hasdai D. Catheter Cardiovasc Interv; 2006 Jul 15; 68(1):56-61. PubMed ID: 16763985 [Abstract] [Full Text] [Related]
16. [Safety of aspirin, clopidogrel, and acenocumarol combination in patients requiring anticoagulation]. Sánchez-Torrijos J, Gudín-Uriel M, Ridocci-Soriano F. Rev Esp Cardiol; 2006 Dec 15; 59(12):1345-6. PubMed ID: 17194433 [No Abstract] [Full Text] [Related]
17. [Recommendations for peri-procedural thrombocyte aggregation inhibition]. Sauer H, Leschke M. Dtsch Med Wochenschr; 2006 Feb 24; 131(8):400-2. PubMed ID: 16479474 [No Abstract] [Full Text] [Related]
18. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions. Faza NN, Mentias A, Parashar A, Chaudhury P, Barakat AF, Agarwal S, Wayangankar S, Ellis SG, Murat Tuzcu E, Kapadia SR. Catheter Cardiovasc Interv; 2017 Feb 01; 89(2):E64-E74. PubMed ID: 27220088 [Abstract] [Full Text] [Related]
19. Which patients receiving warfarin can be treated safely with a drug-eluting stent? Ryding AD, Banning AP. Heart; 2008 Mar 01; 94(3):275-7. PubMed ID: 18276815 [No Abstract] [Full Text] [Related]
20. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? Hermann A, Dzialowski I, Koch R, Gahn G. J Neurol Sci; 2009 Sep 15; 284(1-2):155-7. PubMed ID: 19473668 [Abstract] [Full Text] [Related] Page: [Next] [New Search]